STAAB THOMAS R II
Chief Financial Officer
STAAB THOMAS R II has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including TENX, LNSR, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Sep 16, 2026.
On the most recent filing, STAAB THOMAS R II is listed as Chief Financial Officer at TENAX THERAPEUTICS, INC. Inside the rolling window, STAAB THOMAS R II reported 1 open-market purchase totaling $11K in TENX and no open-market sales.
Companies traded
Other insiders at TENX
Insider Buying
$11K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has STAAB THOMAS R II made?
STAAB THOMAS R II has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including TENX, LNSR since 2026.
Which companies does STAAB THOMAS R II trade?
STAAB THOMAS R II has filed SEC Form 4 disclosures for 2 companies, including TENX, LNSR.
When was STAAB THOMAS R II's most recent SEC Form 4 filing?
STAAB THOMAS R II's most recent SEC Form 4 filing on Tracefour is dated Sep 16, 2026.
What is STAAB THOMAS R II's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, STAAB THOMAS R II is listed as Chief Financial Officer.
What is STAAB THOMAS R II's total buy and sell value in the current window?
Inside the rolling retention window, STAAB THOMAS R II bought $11K and sold $0 based on SEC Form 4 filings.
What was STAAB THOMAS R II's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,675 TENX shares on 2026-09-11, worth $11K, per SEC Form 4 filings.